Practical Considerations for Recognizing, Diagnosing, and Managing Non-Cystic Fibrosis Bronchiectasis: A Care Team Forum®

Program Overview

The goal of this activity is to raise awareness of and educate on the diagnostic testing and multifaceted management essential for patients with NCFBE. Clinicians will learn about the important role of neutrophil serine proteases (NSPs) in NCFBE pathophysiology, including emerging therapies that target neutrophilic inflammation. An experienced patient with NCFBE shares her difficult diagnostic and therapeutic journey and provides impactful insights for clinical care.

1.00 CE Credit(s)

Expires: June 27, 2023

Target Audience

This activity is intended for pulmonary, infectious diseases, radiology, and primary care clinicians who manage patients with non-cystic fibrosis bronchiectasis (NCFBE).

Educational Objectives

Upon successful completion of this educational activity, participants should be better able to:

Apply current criteria for diagnosing non-cystic fibrosis bronchiectasis (NCFBE)
Employ current management strategies for the treatment of patients with NCFBE
Examine the role of neutrophil serine proteases (NSPs) in the pathophysiology of NCFBE
Assess the potential impact of emerging therapies targeting NSPs on the treatment of NCFBE

Activity Faculty

Doreen J. Addrizzo-Harris, MD (Chair)

Professor, Medicine
Associate Director, Clinical and Academic Affairs
Director, NYU Bronchiectasis/NTM Program
NYU Grossman School of Medicine
New York, NY

Charles L. Daley, MD

Chief, Division of Mycobacterial & Respiratory Infections
Professor, Medicine
National Jewish Health
Denver, CO

Anne E. O’Donnell, MD

Professor, Medicine
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Georgetown University Medical Center
Washington, DC

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by independent medical education grants from Insmed

Featured RMEI CE Activities

Practical Considerations for Recognizing, Diagnosing, and Managing Non-Cystic Fibrosis Bronchiectasis: A Care Team Forum®

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Doreen J. Addrizzo-Harris, MD (Chair)

Charles L. Daley, MD

Anne E. O’Donnell, MD

Provider Statement

Supporter Statement

Quelling the Vicious Vortex: Targeting Neutrophil Serine Proteases in Non-Cystic Fibrosis Bronchiectasis

Navigating the Frontier of Hematologic Malignancy Therapies. Series of 5 Modules

Cell-Free DNA Potential in Guiding Therapies and Q&A – Module 5

PROTACs: A Paradigm Shift in Drug Discovery – Module 3

Join Our Network

Company

CE Accreditation

HIPAA Verified & Compliant

Subscribe